RxSight (RXST) Change in Cash (2020 - 2026)
RxSight (RXST) posted Change in Cash of -$2.4 million for Q1 2026, up 75.46% on a QoQ basis from -$9.7 million in Q4 2025, and down 121.04% year-over-year from $11.3 million in Q1 2025.
RxSight (RXST) Change in Cash (2020 - 2026) Analysis & Trends
RxSight's Change in Cash history runs 7 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- Quarterly Change in Cash fell 121.04% year-over-year to -$2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.4 million (down 126.33% YoY) and the FY2025 annual result came in at $3.2 million, down 54.02% from the prior year.
- Change in Cash was -$2.4 million for Q1 2026 at RxSight, up from -$9.7 million in the prior quarter.
- Across five years, Change in Cash topped out at $23.0 million in Q1 2024 and bottomed at -$15.1 million in Q3 2022.
- A 5-year average of -$402882.4 and a median of -$229000.0 in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash jumped 2892.46% — and 2025, when it sank 40445.83%.
- RxSight's Change in Cash stood at $2.9 million in 2022, then plunged by 105.78% to -$166000.0 in 2023, then jumped by 114.46% to $24000.0 in 2024, then sank by 40445.83% to -$9.7 million in 2025, then surged by 75.46% to -$2.4 million in 2026.
- Business Quant data shows RXST's Change in Cash at -$2.4 million in Q1 2026, -$9.7 million in Q4 2025, and -$10.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.72 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.13 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -504.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -492.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | -2.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.38 Mn |
| Dec 31, 2025 | -9.68 Mn |
| Sep 30, 2025 | -10.72 Mn |
| Jun 30, 2025 | 12.36 Mn |
| Mar 31, 2025 | 11.29 Mn |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | -7.73 Mn |
| Jun 30, 2024 | -8.20 Mn |
| Mar 31, 2024 | 22.95 Mn |
| Dec 31, 2023 | -166,000.00 |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | -2.26 Mn |
| Mar 31, 2023 | -822,000.00 |
| Dec 31, 2022 | 2.87 Mn |
| Sep 30, 2022 | -15.09 Mn |
| Jun 30, 2022 | -128,000.00 |
| Mar 31, 2022 | -229,000.00 |
| Dec 31, 2021 | -43.67 Mn |
| Sep 30, 2021 | 26.55 Mn |
| Jun 30, 2021 | 17.45 Mn |